BRPI0414701A - use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kit - Google Patents
use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kitInfo
- Publication number
- BRPI0414701A BRPI0414701A BRPI0414701-4A BRPI0414701A BRPI0414701A BR PI0414701 A BRPI0414701 A BR PI0414701A BR PI0414701 A BRPI0414701 A BR PI0414701A BR PI0414701 A BRPI0414701 A BR PI0414701A
- Authority
- BR
- Brazil
- Prior art keywords
- vitamin
- compound
- prevention
- treatment
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Abstract
"USO DE UM COMPOSTO DE VITAMINA D, MéTODO DE PREVENçãO OU TRATAMENTO DE DISFUNçãO DA BEXIGA EM UM PACIENTE, COMPOSTO DE VITAMINA D, E, KIT". Proporciona-se, de acordo com a invenção, o uso de compostos de Vitamina D, como 1-alfa-fluoro-25-hidróxi-16,23 e-dieno-26,77-bis-homo-20-epi-colecalciferol na prevenção ou no tratamento de disfunção da bexiga."USE OF A VITAMIN D COMPOUND, METHOD OF PREVENTION OR TREATMENT OF BLADDER DYfunction IN A PATIENT, VITAMIN D, E, KIT COMPOUND". According to the invention there is provided the use of Vitamin D compounds such as 1-alpha-fluoro-25-hydroxy-16,23 e-diene-26,77-bis-homo-20-epi-cholecalciferol in prevention or treatment of bladder dysfunction.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0322395A GB0322395D0 (en) | 2003-09-24 | 2003-09-24 | Methods for treating bladder dysfunction and related compounds and compositions |
GB0325598A GB2407499B (en) | 2003-11-03 | 2003-11-03 | Vitamin D3 analogue for use in the treatment of BPH |
GB0404567A GB0404567D0 (en) | 2004-03-01 | 2004-03-01 | Methods for treating bladder dysfunction and related compounds and compositions |
GB0404571A GB0404571D0 (en) | 2004-03-01 | 2004-03-01 | Methods for treating interstitial cystitis and related compounds and compositions |
GB0416876A GB0416876D0 (en) | 2004-07-29 | 2004-07-29 | Compound and use in treatment |
PCT/US2004/031532 WO2005030223A1 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0414701A true BRPI0414701A (en) | 2006-11-14 |
Family
ID=34397209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414701-4A BRPI0414701A (en) | 2003-09-24 | 2004-09-24 | use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kit |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070054887A1 (en) |
EP (1) | EP1663250A4 (en) |
JP (1) | JP2007506780A (en) |
AU (1) | AU2004275845A1 (en) |
BR (1) | BRPI0414701A (en) |
CA (1) | CA2540325A1 (en) |
IL (1) | IL174369A0 (en) |
WO (1) | WO2005030223A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005216651A1 (en) * | 2004-03-01 | 2005-09-09 | Bioxell Spa | Treatment of interstitial cystitis with vitamin D compounds |
AU2005289664A1 (en) * | 2004-09-24 | 2006-04-06 | Bioxell S.P.A. | 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof |
CA2586679A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
WO2009026537A1 (en) * | 2007-08-23 | 2009-02-26 | Theracos, Inc. | Benzylbenzene derivatives and methods of use |
US7737028B2 (en) * | 2007-09-28 | 2010-06-15 | Applied Materials, Inc. | Selective ruthenium deposition on copper materials |
US8222236B2 (en) * | 2008-07-10 | 2012-07-17 | Wisconsin Alumni Research Foundation | 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs |
US20150246061A1 (en) * | 2012-10-19 | 2015-09-03 | Celus Pharmaceuticals, Inc. | Vitamin d analogues for the treatment of a neurological disorder |
CN108884615A (en) * | 2016-03-24 | 2018-11-23 | 大和纺控股株式会社 | Non-woven fabrics and its manufacturing method with decorative pattern |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795882A (en) * | 1992-06-22 | 1998-08-18 | Bone Care International, Inc. | Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
TW403735B (en) * | 1995-11-22 | 2000-09-01 | Hoffmann La Roche | 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol |
US5747479A (en) * | 1996-01-03 | 1998-05-05 | Hoffmann-La Roche Inc. | Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin |
US5939408A (en) * | 1996-05-23 | 1999-08-17 | Hoffman-La Roche Inc. | Vitamin D3 analogs |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
US5872113A (en) * | 1997-05-16 | 1999-02-16 | Syntex (U.S.A.) Inc. | Fluorinated vitamin D3 analogs |
US5811414A (en) * | 1997-05-16 | 1998-09-22 | Hoffmann-La Roche Inc. | Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin |
US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
AU2004235775A1 (en) * | 2003-04-30 | 2004-11-18 | Bioxell S.P.A. | Gemini vitamin D3 compounds and methods of use thereof |
US20070032461A1 (en) * | 2003-04-30 | 2007-02-08 | Bioxell S.P.A. | 1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
-
2004
- 2004-09-24 JP JP2006528270A patent/JP2007506780A/en not_active Abandoned
- 2004-09-24 CA CA002540325A patent/CA2540325A1/en not_active Abandoned
- 2004-09-24 WO PCT/US2004/031532 patent/WO2005030223A1/en active Application Filing
- 2004-09-24 AU AU2004275845A patent/AU2004275845A1/en not_active Abandoned
- 2004-09-24 EP EP04789064A patent/EP1663250A4/en not_active Withdrawn
- 2004-09-24 US US10/573,164 patent/US20070054887A1/en not_active Abandoned
- 2004-09-24 BR BRPI0414701-4A patent/BRPI0414701A/en not_active IP Right Cessation
-
2006
- 2006-03-16 IL IL174369A patent/IL174369A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004275845A1 (en) | 2005-04-07 |
IL174369A0 (en) | 2006-08-01 |
WO2005030223A1 (en) | 2005-04-07 |
CA2540325A1 (en) | 2005-04-07 |
US20070054887A1 (en) | 2007-03-08 |
EP1663250A4 (en) | 2006-12-20 |
JP2007506780A (en) | 2007-03-22 |
EP1663250A1 (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS2517B (en) | Use of substituted 2-aminotetralins in the prevention of Parkinson's disease | |
BR0310092A (en) | Combination of Organic Compounds | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
MEP42808A (en) | Use of flibanserin in the treatment of sexual disorders | |
ECSP056210A (en) | PREPARATION AND USE OF RENTAL DERIVATIVES FOR THE TREATMENT OF OBESITY | |
EA200802213A1 (en) | METHODS OF TREATING BLOOD DISEASES | |
ECSP055964A (en) | HETEROCICLIL-3-SULPHONYLINDAZOLS AS LIGANDS OF 5-HYDROXYTHYRIPTAMINE-6 | |
NO20052787L (en) | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents | |
BR0309343A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions. | |
DOP2002000429A (en) | IMIDAZOTRIAZINAS | |
BR0209129A (en) | Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds. | |
CY1107747T1 (en) | Substituted tetraacyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
BR0309342A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions. | |
BR0116481A (en) | Heterocyclylalkylindole or azaindole compounds as 5-hydroxytryptamine-6 ligands | |
ES2328496T3 (en) | 1,4,8-TRIAZA-ESPIRO (4,5) DECAN-2-ONA SUBSTITUTED COMPOUNDS. | |
BRPI0409359A (en) | somatostatin-dopamine chimeric analogs | |
BR0109163A (en) | Use of pyrido [3,2-e] -pyrazinones as phosphodietherase 5 inhibitors for erectile dysfunction therapy | |
PE20030061A1 (en) | 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS | |
BRPI0508333A (en) | use of a vitamin d compound, method of preventing and / or treating interstitial cystitis, pharmaceutical formulation, vitamin d compound, and kit | |
UY28313A1 (en) | NONADEPSIPEPTIDOS ACILADOS | |
BRPI0414701A (en) | use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kit | |
UY28542A1 (en) | ANTIBACTERIAL MACROCYCLIC AMIDES | |
BR0213317A (en) | Use of a compound, method of treating a gastrin-related disorder, pharmaceutical composition, kit, uses of a composition, and a proton pump inhibitor, methods of preparing a pharmaceutical composition and a compound, and, compound | |
UA83821C2 (en) | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain | |
BRPI0507157A (en) | use of factor viia or equivalent factor viia, parts kit for treating trauma, and methods for treating trauma and for preventing, treating trauma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |